NASDAQ:SIEN - Sientra Stock Price, Forecast & News

Sientra trades on the NASDAQ under the ticker symbol "SIEN."

Sientra Inc (NASDAQ:SIEN) released its quarterly earnings data on Thursday, November, 7th. The medical instruments supplier reported ($0.45) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.02. The medical instruments supplier had revenue of $22.41 million for the quarter, compared to analysts' expectations of $20.05 million. Sientra had a negative return on equity of 122.95% and a negative net margin of 143.76%. Sientra's revenue was up 32.8% compared to the same quarter last year. During the same period last year, the firm posted ($0.72) earnings per share. View Sientra's Earnings History.

Sientra is scheduled to release their next quarterly earnings announcement on Tuesday, March 10th 2020. View Earnings Estimates for Sientra.

Sientra updated its fourth quarter 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $23.2-23.2 million, compared to the consensus revenue estimate of $22.74 million.

8 Wall Street analysts have issued 12 month target prices for Sientra's stock. Their forecasts range from $10.00 to $27.00. On average, they anticipate Sientra's stock price to reach $15.75 in the next twelve months. This suggests a possible upside of 120.6% from the stock's current price. View Analyst Price Targets for Sientra.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sientra.

News headlines about SIEN stock have been trending somewhat positive on Thursday, InfoTrie reports. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Sientra earned a coverage optimism score of 1.6 on InfoTrie's scale. They also assigned headlines about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Sientra.

Sientra saw a increase in short interest in December. As of December 13th, there was short interest totalling 2,530,000 shares, an increase of 7.2% from the November 28th total of 2,360,000 shares. Based on an average daily trading volume, of 627,400 shares, the short-interest ratio is currently 4.0 days. Approximately 5.9% of the shares of the stock are short sold. View Sientra's Current Options Chain.

Some companies that are related to Sientra include Inogen (INGN), Establishment Labs (ESTA), RTI Surgical (RTIX), Invacare (IVC), Lakeland Industries (LAKE), ConforMIS (CFMS), Histogenics (HSGX), COLLPLANT HOLDI/S (CLGN), Rewalk Robotics (RWLK), NanoVibronix (NAOV), Precision Therapeutics (POAI), Ocugen (OCGN), Bionik Laboratories (BNKL), Allied Healthcare Products (AHPI) and Avitar (AVTI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Sientra investors own include Genocea Biosciences (GNCA), Verizon Communications (VZ), Novavax (NVAX), Regions Financial (RF), AT&T (T), Baidu (BIDU), Idera Pharmaceuticals (IDRA), Rigel Pharmaceuticals (RIGL), Allergan (AGN) and Oasis Petroleum (OAS).

Sientra's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Assenagon Asset Management S.A. (0.99%). Company insiders that own Sientra stock include Jeffrey M Nugent, Keith J Sullivan, Patrick F Williams, Paul Sean Little, R Scott Greer and Timothy Haines. View Institutional Ownership Trends for Sientra.

SIEN stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A.. Company insiders that have bought Sientra stock in the last two years include Jeffrey M Nugent, Keith J Sullivan, Patrick F Williams, Paul Sean Little, R Scott Greer and Timothy Haines. View Insider Buying and Selling for Sientra.

Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SIEN stock can currently be purchased for approximately $7.14.

Sientra has a market capitalization of $353.29 million and generates $68.13 million in revenue each year. The medical instruments supplier earns $-82,630,000.00 in net income (profit) each year or ($3.25) on an earnings per share basis. Sientra employs 259 workers across the globe.View Additional Information About Sientra.

The official website for Sientra is http://www.sientra.com/.

Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected]